Cardiovascular outcomes associated with SGLT2 vs DPP4 inhibitors in type 2 diabetic patients with and without established cardiovascular diseases: a propensity score-matched study

25 August 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Professor Bryan Ping Yen Yan

The Chinese University of Hong Kong, Hong Kong (China)

8 More presentations in this session

Presentation thumbnail

Arrythmias and heart rate increase in the LEADER trial and relation to risk of cardiovascular events

Doctor M. Husain (Toronto, CA)

Abstract Slides

Presentation thumbnail

Vascular endothelial growth factor-C and mortality in patients with diabetes and suspected coronary artery disease: from the ANOX study

Doctor T. Unoki (Kumamoto, JP)

Presentation thumbnail

The combined treatment with glucagon like peptide-1 analogues and sodium-glucose co-transporter 2 causes a greater improvement of arterial stiffness than each treatment alone in type 2 diabetes .

Doctor I. Ikonomidis (Athens, GR)

Abstract Slides

Presentation thumbnail

Cardiovascular risk according to add-on therapy in patients with type 2 diabetes

Mr D. Aagaard (Copenhagen, DK)

Presentation thumbnail

Lentiviral transfer of interleukin 4 gene to 3T3-L1 adipocytes prevents development of lipid-induced insulin resistance

Ms S. Michurina (Pavlovo, RU)

Access the full session

Session thumbnail

Poster Session 3 - Diabetes, adiposity and metabolic syndrome

The Event

ESC Congress 2018

25 August - 29 August 2018

You may be interested in

Congress Presentation

Case 1 - a middle-aged male with T2DM: polypharmacy in a primary prevention setting

Congress Presentation

Cardiovascular risk reduction: should we target pre-diabetes?

Webinar

Prevention of heart failure in diabetic patients at population level

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources